Clinical Trial Update: The Effect of 18-month Regimen Containing 6 Anti-tuberculosis Drugs for Patients With MDR-TB [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update evaluating an 18-month regimen containing six anti-tuberculosis drugs for patients with multi-drug resistant tuberculosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multi-drug Resistant Tuberculosis

Snippet

Sponsor: Beijing Chest Hospital | Conditions: Multi-drug Resistant Tuberculosis | Phase 4 | Status: COMPLETED